1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Novartis Patient Assistance Program is sponsored by Novartis Patient Assistance Foundation. The Novartis Patient Assistance Foundation (NPAF) provides Novartis medications free of cost to eligible patients who have limited or no prescription insurance coverage and cannot afford the cost of their medication. The program covers a wide range of Novartis-manufactured medications for various chronic and serious medical conditions.
Geographic focus: United States and US Territories
Focus areas: Healthcare, Patient Assistance, Medication Access
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Novartis Patient Assistance Foundation For US Residents Novartis Patient Assistance Foundation Check Eligibility Download Forms Committed to providing access to Novartis medications for those most in need Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, health care professionals, and societies are empowered in the face of serious disease.
Novartis Patient Assistance Foundation, Inc. (NPAF) is an independent, non-profit organization which provides Novartis medications free of cost to eligible patients. To be eligible, patients must: Reside in the United States or a US Territory Be treated by a licensed US health care provider (HCP) on an outpatient basis Meet income guidelines (Alaska and Hawaii will have different income limits) Check your eligibility here .
View the full list of medications supported by the NPAF program . If you don’t see your Novartis medication listed, it isn’t supported by the NPAF program at this time. If it appears you may qualify, you and your HCP will need to complete your section of the application.
If your application is not complete, you will receive a letter with next steps. You will also receive a text message if you have opted in. You will receive a letter with the outcome of your application within 4 weeks.
Click here for details on how to obtain your medication once approved. Frequently Asked Questions I have questions about the application process How will I get my medication? What can I do if my application is denied?
Novartis Patient Assistance Foundation, Inc. (NPAF) is an independent, 501(c)(3) non-profit entity that provides certain medications at no cost to eligible patients who cannot afford the cost of their Novartis medication, are uninsured or have government insurance, and meet income guidelines and other eligibility criteria.
NPAF does not provide product to individuals having insurance associated with any type of alternate funding program that conditions, restricts, or adjusts coverage based on application to NPAF or any other free goods program. Other Terms and Conditions may apply To receive support through NPAF, applicants must submit all required documentation, including proof of income and evidence of Extra Help denial as deemed necessary.
Only the patient or their legal guardian or caregiver may enroll the patient in the program. Health plans, specialty pharmacies, pharmacy benefit managers, and their agents and representatives are prohibited from enrolling patients in the program.
Novartis Patient Assistance Foundation, Inc., at its sole and absolute discretion, reserves the right to modify or discontinue the program at any time and to verify the accuracy of enrollment information submitted. Call NPAF at 1-800-277-2254 . FAX: 1-855-817-2711 or US Mail: PO Box 2529 Columbus, OH 43216 © 2024 Novartis Pharmaceuticals Corporation Novartis Site Directory This site is intended for US residents only
According to the current listing, eligibility includes: Applicants must be residents of the United States or a US Territory, be treated by a licensed US healthcare provider on an outpatient basis, and meet specific income guidelines (typically between 250% and 500% of the Federal Poverty Level depending on the specific medication). Patients must have limited or no private or public prescription coverage. Confirm the full requirements in the official notice before applying.
Novartis Patient Assistance Program is funded by Novartis Patient Assistance Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The FY2028 Fund for Veterans' Assistance cycle opened October 2, 2026 with an estimated $31 million, awards from $50,000 to $600,000, and a 24-month term. TVC's own cumulative figures show the last cycle landed well above the advertised estimate — and the lottery revenue behind it now has a 2029 sunset date.
Read articleCDC-RFA-DD-26-0222 closes October 26, 2026 with two components, 14 to 20 expected awards, and a scoring sheet that hands out 20 of 40 approach points for chart volume between January 2020 and August 2024. The grants.gov summary fields also understate the program by two-thirds.
Read articleOn September 16, 2026, the First Circuit granted HUD an emergency stay of the order that had erased the FY2026 Continuum of Care competition. HUD reopened e-snaps on September 18 with a September 30, 8:00 PM ET deadline, one technical correction shortening applicant notification from 15 days to 7, and a waiver letting private nonprofits administer rental assistance. Here is what the stay does and does not decide, why your award may still be provisional, and the exact sequence to run in the days you have left.
Read article